Abbott Laboratories (ABT)

Currency in USD
126.54
+0.90(+0.72%)
Closed·
After Hours
126.26-0.28(-0.22%)
·

ABT Financial Summary

Key Ratios

P/E Ratio15.77
Price/Book4.41
Debt / Equity27.09%
Return on Equity30.65%
Dividend Yield1.88%
EBITDA10.71B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
* In Millions of USD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 8.01%
Dividend Yield
1.87%
Industry Median 1.31%
Annualised payout
2.36
Paid quarterly
5-Years Growth
+10.63%
Growth Streak

Analyst Ratings

20 Buy
8 Hold
1 Sell
Ratings:
29 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 141.62
(+11.92% Upside)

Earnings

Latest Release
Jul 17, 2025
EPS / Forecast
1.26 / 1.25
Revenue / Forecast
11.42B / 11.07B
EPS Revisions
Last 90 days

FAQ

What were Abbott Labs's earnings for the latest quarter?

The Abbott Labs EPS (TTM) is 8.01. Abbott Labs reported sales of 11,142.00, net income of 1,779.00, and EPS of 1.26 for the latest quarter.

What was Abbott Labs's net income for the latest quarter?

Abbott Labs's net income for the latest quarter was 1,779.00.

How did Abbott Labs's performance compare year-over-year in the latest quarter?

The company's revenue moved from 10,358.00 in the previous quarter to 11,142.00 in the latest quarter, and net income moved from 1,325.00 to 1,779.00 compared to the previous quarter.

What is Abbott Labs's net profit margin on a TTM basis?

Abbott Labs's trailing twelve months (TTM) net profit margin is 31.95%.

How does Abbott Labs's debt to equity ratio compare to industry standards?

Abbott Labs's total debt-to-equity ratio is 27.09%.

What is Abbott Labs's return on investment on a TTM basis?

Abbott Labs's trailing twelve months (TTM) return on investment (ROI) is 30.65%.

How has Abbott Labs's total revenue grown this year?

Abbott Labs's total revenue was 10,358.00 in the previous quarter and 11,142.00 in the latest quarter.

What is Abbott Labs's gross margin on a TTM basis?

Abbott Labs's trailing twelve months (TTM) gross margin is 56.17%.

What was Abbott Labs's revenue per share for the latest quarter?

Abbott Labs's revenue per share for the latest quarter was 31.41.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.